IBM SPSS Modeler Pricing Overview

No. According to G2 data, IBM SPSS Modeler does not offer a free plan or free trial. Users need to purchase a paid plan to access the product. Visit the seller's official pricing page for current pricing details and plan options.

IBM SPSS Modeler's pricing is best suited for enterprise and mid-market organizations with dedicated analytics teams and substantial budgets. G2 reviewers from banking, healthcare, market research, and education industries represent the most active user base, with enterprise-segment reviewers frequently citing use cases like churn prediction, customer segmentation, and fraud prevention. The IBM SPSS Modeler Personal tier suits individual analysts or researchers needing core modeling capabilities, while IBM SPSS Modeler Professional and Premium tiers align with larger teams requiring advanced text analytics, big data integration, and model deployment. G2 reviewers from small businesses and academic institutions note that pricing can be prohibitive without institutional or organizational funding.

IBM SPSS Modeler does not offer a free version. According to G2's pricing data for IBM SPSS Modeler, the entry-level IBM SPSS Modeler Personal tier starts at $4,950 USD and includes core capabilities such as data access without size limits, automatic data prep and ETL, 30+ machine learning algorithms, and R and Python scripting. IBM SPSS Modeler's higher tiers, Professional at $7,430 USD and Premium at $12,300 USD, add in-database mining, SQL pushback, model management, version control, Hadoop and Spark support, champion/challenger testing, and text and entity analytics. Enterprise custom pricing is also available through IBM sales.

IBM SPSS Modeler's pricing is considered a premium investment that delivers strong analytical capabilities, though cost is a recurring concern across G2 reviews. With an overall rating of 4.5/5, most G2 reviewers acknowledge the software's power for predictive analytics, data preparation, and machine learning. However, multiple G2 reviewers across enterprise and mid-market segments explicitly flag high per-user licensing costs as a significant drawback, particularly for multi-team deployments. Reviewers in banking, healthcare, and research tend to justify the expense given the depth of capabilities. Some G2 reviewers compare it unfavorably to open-source alternatives like R and Python for cost-conscious users or advanced data scientists.